The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives-Reference-Cited by-同舟云学术

The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives

Published:2022-12-21 Issue:4 Volume:35 Page:
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Dookie Navisha¹^ORCID,Ngema Senamile L.¹,Perumal Rubeshan¹²,Naicker Nikita¹²,Padayatchi Nesri¹²,Naidoo Kogieleum¹²

Affiliation:

1. Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa

2. South African Medical Research Council–CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa

Abstract

Drug-resistant tuberculosis (DR-TB) remains a global crisis due to the increasing incidence of drug-resistant forms of the disease, gaps in detection and prevention, models of care, and limited treatment options. The DR-TB treatment landscape has evolved over the last 10 years.

Funder

EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership

National Research Foundation

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/cmr.00180-19

Reference189 articles.

1. World Health Organization. 2018. Global tuberculosis report 2018. WHO Geneva Switzerland. https://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf.

2. World Health Organization. 2021. Global tuberculosis report 2021. WHO Geneva Switzerland. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.

3. World Health Organization. 2020. Global tuberculosis report 2020. WHO Geneva Switzerland. https://www.who.int/publications/i/item/9789240013131.

4. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

5. World Health Organization. 2020. WHO consolidated guidelines on tuberculosis. Module 4: drug-resistant tuberculosis treatment. WHO Geneva Switzerland. https://www.who.int/publications/i/item/9789240007048.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of emerging drugs for the treatment of multi-drug resistant tuberculosis;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2024-12

2. ACURAT: Advancing tuberculosis detection through assembled PCR & CRISPR for ultra-sensitive Rifampin-resistant analysis testing;Chemical Engineering Journal;2024-08

3. Complete genome of a novel mycobacteriophage WXIN isolated in Wuhan, China;BMC Genomic Data;2024-06-18

4. Identification of urine biomarkers predictive of prolonged QTc interval in multidrug-resistant tuberculosis patients treated with bedaquiline;Frontiers in Pharmacology;2024-05-30

5. Current landscape of exosomes in tuberculosis development, diagnosis, and treatment applications;Frontiers in Immunology;2024-05-23